During the past decade, Aesthetic Solutions, PA conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Aesthetic Solutions, PA" are "Age-related Volume Deficit in the Mid-face" (1 trials), "Bilateral Nasolabial Fold Wrinkles" (1 trials), "Central Abdominal Bulging" (1 trials), "Glabellar Frown Lines" (1 trials) and "Infraorbital Hollowing" (1 trials). Many other conditions were trialed in "Aesthetic Solutions, PA" in a lesser frequency.

Most popular intervention types in "Aesthetic Solutions, PA" are "Device" (4 trials), "Biological" (3 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Autologous Human Fibroblast (azficel-T)" (1 trials), "Device: FDA Approved Dermal Filler" (1 trials), "JUVÉDERM VOLBELLA® XC injectable gel" (1 trials) and "JUVÉDERM VOLUMA® XC injectable gel with cannula" (1 trials). Other intervention names were less common.

The vast majority of trials in "Aesthetic Solutions, PA" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Aesthetic Solutions, PA". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Aesthetic Solutions, PA, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Aesthetic Solutions, PA, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".